• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells

tetano

Editor, Senior Moderator
J Virol


. 2022 Jul 5;e0060822.
doi: 10.1128/jvi.00608-22. Online ahead of print.
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells


Sophie-Marie Aicher[SUP] #[/SUP][SUP] 1 [/SUP], Felix Streicher[SUP] #[/SUP][SUP] 1 [/SUP], Maxime Chazal[SUP] #[/SUP][SUP] 1 [/SUP], Delphine Planas[SUP] #[/SUP][SUP] 2 3 [/SUP], Dongsheng Luo[SUP] #[/SUP][SUP] 4 [/SUP], Julian Buchrieser[SUP] #[/SUP][SUP] 2 [/SUP], Monika Nemcova[SUP] #[/SUP][SUP] 5 [/SUP], Veronika Seidlova[SUP] #[/SUP][SUP] 5 [/SUP], Jan Zukal[SUP] #[/SUP][SUP] 6 [/SUP], Jordi Serra-Cobo[SUP] #[/SUP][SUP] 7 8 [/SUP], Dominique Pontier[SUP] #[/SUP][SUP] 9 10 [/SUP], Bertrand Pain[SUP] #[/SUP][SUP] 11 [/SUP], Gert Zimmer[SUP] #[/SUP][SUP] 12 13 [/SUP], Olivier Schwartz[SUP] #[/SUP][SUP] 2 3 [/SUP], Philippe Roingeard[SUP] #[/SUP][SUP] 14 [/SUP], Jiri Pikula[SUP] #[/SUP][SUP] 5 [/SUP], Laurent Dacheux[SUP] #[/SUP][SUP] 4 [/SUP], Nolwenn Jouvenet[SUP] #[/SUP][SUP] 1 [/SUP]



Affiliations

Abstract

Bats are natural reservoirs of numerous coronaviruses, including the potential ancestor of SARS-CoV-2. Knowledge concerning the interaction between coronaviruses and bat cells is sparse. We investigated the ability of primary cells from Rhinolophus and Myotis species, as well as of established and novel cell lines from Myotis myotis, Eptesicus serotinus, Tadarida brasiliensis, and Nyctalus noctula, to support SARS-CoV-2 replication. None of these cells were permissive to infection, not even the ones expressing detectable levels of angiotensin-converting enzyme 2 (ACE2), which serves as the viral receptor in many mammalian species. The resistance to infection was overcome by expression of human ACE2 (hACE2) in three cell lines, suggesting that the restriction to viral replication was due to a low expression of bat ACE2 (bACE2) or the absence of bACE2 binding in these cells. Infectious virions were produced but not released from hACE2-transduced M. myotis brain cells. E. serotinus brain cells and M. myotis nasal epithelial cells expressing hACE2 efficiently controlled viral replication, which correlated with a potent interferon response. Our data highlight the existence of species-specific and cell-specific molecular barriers to viral replication in bat cells. These novel chiropteran cellular models are valuable tools to investigate the evolutionary relationships between bats and coronaviruses. IMPORTANCE Bats are host ancestors of several viruses that cause serious disease in humans, as illustrated by the ongoing SARS-CoV-2 pandemic. Progress in investigating bat-virus interactions has been hampered by a limited number of available bat cellular models. We have generated primary cells and cell lines from several bat species that are relevant for coronavirus research. The various permissivities of the cells to SARS-CoV-2 infection offered the opportunity to uncover some species-specific molecular restrictions to viral replication. All bat cells exhibited a potent entry-dependent restriction. Once this block was overcome by overexpression of human ACE2, which serves at the viral receptor, two bat cell lines controlled well viral replication, which correlated with the inability of the virus to counteract antiviral responses. Other cells potently inhibited viral release. Our novel bat cellular models contribute to a better understanding of the molecular interplays between bat cells and viruses.

Keywords: SARS-CoV-2; bat cells; coronavirus; innate immunity.
 
Back
Top Bottom